Author: digi

Inspection Findings on Inadequate Changeover Cleaning Controls

Posted on By digi

Inspection Findings on Inadequate Changeover Cleaning Controls Step-by-Step Tutorial for Effective Changeover Cleaning Between Different Products The pharmaceutical industry is highly regulated to ensure patient safety and product quality. Among the numerous GMP requirements, changeover cleaning between different products plays a critical role in preventing cross-contamination, residues, and mix ups. Regulatory agencies including the FDA,…

Read More “Inspection Findings on Inadequate Changeover Cleaning Controls” »

Changeover Cleaning

Dirty Hold Time and Clean Hold Time Studies: A GMP Overview

Posted on By digi

Dirty Hold Time and Clean Hold Time Studies: A GMP Overview Step-by-Step Tutorial on Dirty Hold Time and Clean Hold Time Studies in Pharmaceutical GMP Within pharmaceutical manufacturing, maintaining equipment integrity between manufacturing and cleaning activities is critical to avoid contamination risks and ensure product quality. Dirty hold time and clean hold time studies form…

Read More “Dirty Hold Time and Clean Hold Time Studies: A GMP Overview” »

Hold Time (Dirty/Clean)

How to Design and Execute Dirty Hold Time Studies for Equipment

Posted on By digi

How to Design and Execute Dirty Hold Time Studies for Equipment Step-by-Step Guide to Designing and Executing Dirty Hold Time Studies for Pharmaceutical Equipment Understanding and controlling equipment hold times — both dirty and clean — is critical in pharmaceutical manufacturing environments to maintain product quality and compliance. Dirty hold time and clean hold time…

Read More “How to Design and Execute Dirty Hold Time Studies for Equipment” »

Hold Time (Dirty/Clean)

Cleaning Agents Selection for Pharma Equipment: Science and GMP

Posted on By digi

Cleaning Agents Selection for Pharma Equipment: Science and GMP Step-by-Step Tutorial for Cleaning Agents Selection for Pharma Equipment Proper selection of cleaning agents is a cornerstone of pharmaceutical Good Manufacturing Practice (GMP) to ensure product quality, patient safety, and regulatory compliance. This tutorial provides a detailed, science-based, and GMP-aligned approach for cleaning agents selection for…

Read More “Cleaning Agents Selection for Pharma Equipment: Science and GMP” »

Cleaning Agents

How to Justify Cleaning Agent Selection in Validation Protocols

Posted on By digi

How to Justify Cleaning Agent Selection in Validation Protocols Step-by-Step Guide to Justifying Cleaning Agent Selection for Pharma Equipment In pharmaceutical manufacturing, the choice of cleaning agents for equipment is a critical decision that impacts product quality, patient safety, and regulatory compliance. Selecting the appropriate cleaning agents and properly documenting their justification within validation protocols…

Read More “How to Justify Cleaning Agent Selection in Validation Protocols” »

Cleaning Agents

Material Compatibility and Corrosion Risks with Cleaning Agents

Posted on By digi

Material Compatibility and Corrosion Risks with Cleaning Agents Step-by-Step Guide to Material Compatibility and Corrosion Risks in Cleaning Agents Selection for Pharma Equipment Ensuring the integrity and operational longevity of pharmaceutical manufacturing equipment is essential for compliance with current Good Manufacturing Practice (cGMP) guidelines. One of the key risk factors threatening equipment reliability is corrosion…

Read More “Material Compatibility and Corrosion Risks with Cleaning Agents” »

Cleaning Agents

Case Studies: Cleaning Agent Selection Leading to Validation Problems

Posted on By digi

Case Studies: Cleaning Agent Selection Leading to Validation Problems Case Studies Demonstrating Challenges in Cleaning Agents Selection for Pharma Equipment In pharmaceutical manufacturing, the cleaning agents selection for pharma equipment is a critical aspect that directly impacts both product quality and regulatory compliance. The inadequate choice of cleaning agents often leads to persistent residues, foaming…

Read More “Case Studies: Cleaning Agent Selection Leading to Validation Problems” »

Cleaning Agents

Changeover Cleaning Between Different Products: GMP Strategy

Posted on By digi

Changeover Cleaning Between Different Products: GMP Strategy Step-by-Step GMP Strategy for Changeover Cleaning Between Different Products In pharmaceutical manufacturing, changeover cleaning between different products is a critical operation to ensure product quality and patient safety. Effective cleaning strategies minimize cross-contamination risks, maintain compliance with Good Manufacturing Practice (GMP) regulations, and support operational efficiency across campaigns….

Read More “Changeover Cleaning Between Different Products: GMP Strategy” »

Changeover Cleaning

Inspection Cases: Visual Cleanliness Failures and Consequences

Posted on By digi

Inspection Cases: Visual Cleanliness Failures and Consequences Understanding Visual Cleanliness Acceptance Criteria in Pharma: Step-by-Step Inspection Case Review and Consequences In pharmaceutical manufacturing, maintaining visual cleanliness acceptance criteria in pharma processes is critical to ensure product safety, efficacy, and regulatory compliance. Visual cleanliness—often the first and most immediate indicator of effective cleaning and contamination control—is…

Read More “Inspection Cases: Visual Cleanliness Failures and Consequences” »

Visual Cleanliness

Cleaning Verification vs Cleaning Validation: What Regulators Expect

Posted on By digi

Cleaning Verification vs Cleaning Validation: What Regulators Expect Understanding Cleaning Verification vs Cleaning Validation: Regulatory Expectations for Pharmaceutical Manufacturing In pharmaceutical manufacturing, cleanliness of equipment and facilities is not only essential for product quality but also mandatory for regulatory compliance. Two pivotal activities to ensure adequate cleaning controls are cleaning verification and cleaning validation. Although…

Read More “Cleaning Verification vs Cleaning Validation: What Regulators Expect” »

Verification vs Validation